As this medium has learned, the Hospital de Dénia He has ordered two local drugs from local pharmacies to combat coronavirus symptoms.
Hospital sources have told us that the shortage of these drugs has forced them to request them from the city's pharmacies, which have also confirmed it to us. Apparently, the distribution lines are prioritizing other health centers in the Valencian Community, so they cannot replace them at the rate they are running out.
This would be a consequence of the distribution control of the entire hydroxychlorine / chloroquine stock announced by the AEMPS. Given the limited stock of these medicines and the increasing demand in very diverse situations related to COVID-19, these products are made available to the autonomous communities, which arbitrate the distribution control system.
"The efficacy of chloroquine and hydroxychloroquine is being evaluated in a number of clinical trials, the results of which have not yet been published. Therefore, the level of evidence is considered to be still low and based on preclinical and clinical data. Safety in other indications Despite its use, it has raised expectations that different authorities (Italy, France, China or Spain) have included chloroquine or hydroxychloroquine as one of the treatment alternatives in patients with COVID infection - 19 ", report from the Spanish Agency for Medicines and Health Products.
These medications are Dolquine and Resochin, antimalarials that are used to treat rheumatoid arthritis, lupus, and malaria. Pharmacies have provided them to the Dénia Hospital, which already have them to continue fighting the pandemic.